Aquilo Capital Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $128 Million distributed in 14 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arrowhead Pharmaceuticals, Inc. with a value of $15.4M, Blueprint Medicines Corp with a value of $11.5M, Kymera Therapeutics, Inc. with a value of $9.88M, Regenxbio Inc. with a value of $9.76M, and Arvinas, Inc. with a value of $9.58M.

Examining the 13F form we can see an increase of $28.5M in the current position value, from $100M to 128M.

Aquilo Capital Management, LLC is based out at San Francisco, CA

Below you can find more details about Aquilo Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $128 Million
Healthcare: $85.4 Million
ETFs: $43 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 14
  • Current Value $128 Million
  • Prior Value $100 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Aquilo Capital Management, LLC Portfolio

Follow Aquilo Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.